2025-1학기 졸업논문발표회 개최 안내 및 참석 요청 | ||
06-25-25 Hit 70 |
2025학년도 1학기 분자의학및바이오제약학과의 졸업논문발표회를 다음과 같이 개최하오니
참석하여 주시기 바랍니다.
코로나 사회적 현상 이루 처음으로 하는 대면 발표회입니다.
바쁘시더라도 꼭 참석하셔서 성원과 격려부탁드립니다.
1. 일시 : 석사_ 7.1.(화) 13:00~16:30, 박사_7.3.(목) 13:00~14:40
2. 장소 : 서울대학교 연건캠퍼스 융합관 양윤선홀
3. 참석대상: 재학생, 수료생 및 관심있는 분
4. 발표순서, 명단, 제목(제목은 변경 될 수 있습니다.)
- 석사: 14명*15분
순번 | 발표시간 | 성명 | 지도교수 | 논문제목 |
1 | 13:00~13:15 | 이상민 | 이주용 | Development of a consensus docking based AI-driven model for virtual screening |
2 | 13:15~13:30 | 서문창 | 이주용 | Evaluating Antigen-Antibody Complexes with AlphaFold3 |
3 | 13:30~13:45 | 이수빈 | 임형준 | Development of Perfluorocarbon and Indocyanine green co-loaded liposomes for Enhanced Sonodynamic Therapy |
4 | 13:45~14:00 | 김보경 | 임형준 | In vivo evaluation of the radiolabeled TSPO-binding radiotracer encapsulated in pH-responsive liposome for targeting cancer |
5 | 14:00~14:15 | 이채림 | 신영기 | Discovery of Therapeutic Anti-RON mAb and Development of Bispecific Antibodies (RON × MET, RON × EGFR) to Overcome Cetuximab Resistance in Colorectal Cancer |
6 | 14:15~14:30 | 박연진 | 신영기 | Immunocytokine with Cleavable Linker for Cancer Immunotherapy |
7 | 14:30~14:45 | 이유림 | 신영기 | Optimization of exosomal PD-L1 detection assay for tracking circulating exosomal PD-L1 to monitor breast cancer patients |
8 | 14:45~15:00 | 이연우 | 신영기 | Development of a CLDN3 Antibody-Based Strategy for Capturing Circulating Tumor Cells in Small Cell Lung Cancer: Comparative and Correlative Analysis of CLDN3-Positive and EpCAM-Positive CTCs with DLL3 and B7-H3 Expression |
9 | 15:00~15:15 | 서주연 | 신영기 | Development of TIGIT X CTLA-4 Bispecific antibody for specifically targeting regulatory T cell in Tumor Micro Environment to enhance anti-cancer immunity |
10 | 15:15~15:30 | 고민영 | 신영기 | Development of a Biparatopic Anti-c-MET Antibody |
11 | 15:30~15:45 | 서재훈 | 이형기 | An Analysis of the Competitiveness and Developmental Challenges of Korea's mRNA-based Drug Development Industry in Comparison with Global Pharmaceutical Leaders |
12 | 15:45~16:00 | 최수빈 | 이은봉 | Roles of resistin aggravating rheumatoid arthritis and efficacy of resistin blocker |
13 | 16:00~16:15 | 구본준 | 이은봉 | Resistin induces liver fibrosis by inhibiting ampk phosphorylation, leading to transcription factor p300 activation |
14 | 16:15~16:30 | 유지훈 | 이은봉 | Resistin inhibits AMPK phosphorylation, disrupting cell integrity, where as RELMβ does not inhibit AMPK |
- 박사 : 4명*25분
순번 | 발표시간 | 성명 | 지도교수 | 논문제목 |
1 | 13:00~13:25 | 이하경 | 변영로 | Caspase-3 cleavable peptide linker and Doppel-targeting antibodies as a strategy to overcome tumor heterogeneity |
2 | 13:25~13:50 | 임수진 | 신영기/오우택 | Molecular basis for selective blockade of Tentonin3/TMEM150C, a mechanosensitive channel by conotoxin-derived peptides |
3 | 13:50~14:15 | 최영희 | 김태유 | Activation of KIT Signaling Promotes Early Tumorigenesis through AP-1 pathway in APC/TP53 Double-Knockout Human Colon Organoids |
4 | 14:15~14:40 | 양혜주 | 김태유 | SMARCA4-mediated enhancer reprogramming drives oncogenic gene expression in lung adenocarcinoma |